Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Nuvalent trots out strong pivotal data in FDA lung cancer push
Nuvalent is eyeing an FDA rolling submission for its ROS1 inhibitor in TKI-pretreated lung cancer after releasing competitive pivotal data.
Angus Liu
Jun 24, 2025 6:30am
Fierce Pharma
UK reveals life sciences plan in sweeping strategy update
Jun 23, 2025 3:55pm
BrightGene tops Novo drug in diabetes ahead of Zepbound showdown
Jun 23, 2025 2:30pm
Fierce Pharma
FDA's acting CDER head heads for the exit: report
Jun 23, 2025 1:48pm
J&J launches daily contact lens for astigmatism, presbyopia
Jun 23, 2025 11:48am
Illumina picks up proteomics developer SomaLogic for $425M
Jun 23, 2025 11:00am
More News
Sanofi signs €545M deal to explore Formation’s JAK/SYK inhibitor
Jun 23, 2025 9:47am
Fierce Biotech Layoff Tracker 2025: Prothena, BioNTech & more
Jun 23, 2025 9:30am
Leap expands layoffs to 75% of staff, scraps last clinical trial
Jun 23, 2025 9:22am
Corxel, Sciwind post data as China's obesity push gathers pace
Jun 23, 2025 9:20am